Although aromatase expression in the brain and the resulting local E2 synthesis have been shown to be important factors in protection against AD, very little is known about how AD influences the expression of aromatase in the human hippocampus, the brain region that is among the first to be affected by AD. Here, CYP19A1 is linked to Alzheimer disease.